Dr. Ison is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5601 Fishers Lane, Room 8E31
North Bethesda, MD 20852- Is this information wrong?
Summary
- Dr. Michael Ison is an transplant infectious diseases specialist. He received his medical degree from University of South Florida Morsani College of Medicine and has been in practice 20 years. He is experienced in general infectious disease, kidney transplantation, liver transplantation, wound management, and respiratory tract infections. He has more than 100 publications and over 500 citings.
Education & Training
- Massachussetts General Hospital/HMSTransplant Infectious Diseases, Transplant Infectious Diseases, 2004 - 2005
- University of VirginiaMS, Health Evaluation Sciences, 2001 - 2004
- University of Virginia Medical CenterFellowship, Infectious Disease, 2004
- Oregon Health & Science UniversityResidency, Internal Medicine, 1997 - 2000
- University of South Florida College of MedicineClass of 1997
Certifications & Licensure
- VA State Medical License 2001 - 2026
- MD State Medical License 2023 - 2024
- IL State Medical License 2005 - 2023
- OR State Medical License 1999 - 2000
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Super Doctor SuperDoctors.com
Clinical Trials
- Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza Start of enrollment: 2010 Dec 01
- Pharmacokinetic Assessment of Peramivir in Hospitalized Adults Undergoing Continuous Renal Replacement Therapy Start of enrollment: 2010 Feb 01
- Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications Start of enrollment: 2010 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Presentation, anagement, and outcomes of norovirus in adult and pediatric solid organ and hematopoietic stem cell transplant recipients: A multicenter, retrospective s...Michelle Callegari, Lara A Danziger-Isakov, Anne Rose, Daniel Kaul, Kelly Shaffer, Pearlie P Chong, Diana Florescu, Kaci German, Robin Avery, M Hong Nguyen, Brett Wild...> ;Transplant Infectious Disease. 2024 Mar 25
- Integration of individualized and population-level molecular epidemiology data to model COVID-19 outcomes.Ted Ling-Hu, Lacy M Simons, Taylor J Dean, Estefany Rios-Guzman, Matthew T Caputo, Arghavan Alisoltani, Chao Qi, Michael Malczynski, Timothy Blanke, Lawrence J Jenning...> ;Cell Reports. Medicine. 2024 Jan 16
- Breakthrough SARS-CoV-2 infections among recipients of tixagevimab-cilgavimab prophylaxis: A citywide real-world effectiveness study.Frances R Lendacki, Linda Li, Graeme N Forrest, Leirah Jordan, Christy Zelinski, Stephanie R Black, Michael G Ison, Jennifer Y Seo> ;Transplant Infectious Disease. 2024 Feb 1
- Join now to see all
Journal Articles
- Emergency Use Authorization of RemdesivirMichael G Ison, Cameron Wolfe, Helen W Boucher, JAMA
- Early Oseltamivir After Hospital Admission Is Associated with Shortened Hospitalization: A Five-Year Analysis of Oseltamivir Timing and Clinical OutcomesMichael G Ison, Rachel Kohn, Clinical Infectious Diseases
- Parainfluenza Virus in Hospitalized Adults: A 7-Year Retrospective StudyMichael G Ison, Elliott Russell, Clinical Infectious Diseases
Other
- Parainfluenza viruses in adultsIson MG
http://www.uptodate.com/contents/parainfluenza-viruses-in-adults
UpToDate, Wolters Kluwer Health - 2012-04-12
Authored Content
- Emergency Use Authorization of RemdesivirMay 2020
Press Mentions
- Vaccine Candidates for RSV Ward off Severe Illness in Older AdultsOctober 26th, 2022
- Feeling Sick After the Flu Shot? Doctors Explains Why — and What to DoSeptember 13th, 2022
- COVID Antiviral Pills Work Against Omicron—When People Can Get ThemJanuary 28th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: